Novel automated biomarker discovery work flow for urinary peptidomics

Area of Science:

• Biochemistry
• Analytical Chemistry
• Proteomics

Background:

• Urine contains valuable peptide biomarkers, but analysis is challenging due to sample variability (e.g., pH, salt).
• Developing a reproducible, high-throughput method is crucial for effective urinary peptidomic analysis and biomarker discovery.

Purpose of the Study:

• To create a generally applicable, rapid, and robust method for screening numerous urine samples.
• To enable the broad spectrum identification of native urinary peptides for biomarker discovery.

Main Methods:

• A miniaturized automated reverse-phase strong cation exchange (RP-SCX) cartridge system was used for peptide trapping, desalting, pH-normalization, and fractionation.
• Peptides were analyzed using MALDI-TOF, Fourier transform ion cyclotron resonance, and liquid chromatography-iontrap mass spectrometry.
• Method reproducibility and robustness were assessed using BSA digests and urine samples, with clinical applicability evaluated on samples from Schistosoma haematobium-infected individuals.

Main Results:

• The automated RP-SCX system demonstrated high qualitative and quantitative reproducibility with both standards and urine samples.
• The method allows for sensitive peptide measurement due to high cartridge binding capacity (1-2 mL urine).
• Hemoglobin-derived peptides were identified in infected individuals' urine, even with negative microhematuria tests.

Conclusions:

• A practical, step-by-step method for screening and identifying urinary peptides has been developed.
• The analytical method's feasibility was confirmed using both standard samples and actual clinical material.